Tapentadol hydrochloride ER
Term · Oncology and biomedicine · MLC-T-ONC-016981
An orally active, extended-release preparation of the hydrochloride salt of tapentadol with analgesic activity. Tapentadol is a synthetic, centrally acting analgesic with a dual mechanism of action involving mu-opioid receptor agonism and norepinephrine reuptake inhibition. This agent may be effective in the management of pain, cancer-related and other.
| Identifier | MLC-T-ONC-016981 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016981",
"term": "Tapentadol hydrochloride ER",
"field": "Oncology and biomedicine",
"definition": "An orally active, extended-release preparation of the hydrochloride salt of tapentadol with analgesic activity. Tapentadol is a synthetic, centrally acting analgesic with a dual mechanism of action involving mu-opioid receptor agonism and norepinephrine reuptake inhibition. This agent may be effective in the management of pain, cancer-related and other.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tapentadol-hydrochloride-er/"
}
Record 15,990 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.